"Das 1980 errichtete Alfried Krupp Krankenhaus in Essen-Rüttenscheid ist Stiftungskrankenhaus der Alfried Krupp von Bohlen und Halbach-Stiftung und akademisches Lehrkrankenhaus der Universität Duisburg-Essen. Es verfügt über 13 Kliniken und 575 Betten."

During the past decade, Alfried Krupp Krankenhaus conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alfried Krupp Krankenhaus" #1 sponsor was "Medtronic Neurovascular Clinical Affairs" with 4 trials, followed by "Aesculap AG" with 1 trials sponsored, "Alfried Krupp Krankenhaus" with 1 trials sponsored, "Biotronik, Inc." with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alfried Krupp Krankenhaus" #1 collaborator was "Medtronic Bakken Research Center" with 2 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Alfried-Krupp Krankenhaus of Essen, Germany" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Ammerland Klinik GmbH, Westerstede, Germany" with 1 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Alfried Krupp Krankenhaus" are "Stroke" (4 trials), "Atrial Fibrillation" (3 trials), "Intracranial Aneurysm" (3 trials), "Stroke, Acute" (2 trials) and "Transient Ischemic Attack" (2 trials). Many other conditions were trialed in "Alfried Krupp Krankenhaus" in a lesser frequency.

Most popular intervention types in "Alfried Krupp Krankenhaus" are "Device" (15 trials), "Drug" (8 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "24-h Holter monitoring" (1 trials), "5-FU" (1 trials), "5-FU and oxaliplatin" (1 trials) and "ASA 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alfried Krupp Krankenhaus" are 25 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Alfried Krupp Krankenhaus". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Alfried Krupp Krankenhaus, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Alfried Krupp Krankenhaus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".